Onconova Therapeutics Competitors and Similar CompaniesClear all
Onconova Therapeutics's competitors and similar companies include Moleculin Biotech, GlycoMimetics, Calithera Biosciences and Kyowa Kirin.
 Onconova Therapeutics Onconova Therapeutics is a biopharmaceutical company developing small molecule drug candidates for the treatment of cancer. |  Moleculin Biotech Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates. |  GlycoMimetics GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers. |  Calithera Biosciences Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer. |  Kyowa Kirin Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system. | |
Founding Date | Founding Date 1998 | Founding Date 2006 | Founding Date 2003 | Founding Date 2010 | Founding Date 2008 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Newtown, US HQ Boston, US Newtown, US Pennington, US | Locations Houston, US HQ | Locations Rockville, US HQ | Locations South San Francisco, US HQ | |
Employees | Employees 1732% decrease | Employees 176% decrease | Employees 5025% increase | Employees 798% increase | Employees 5,669 |
Valuation ($) | Valuation ($) 20.9 m | Valuation ($) 7.5 m | Valuation ($) 31.6 m | Valuation ($) 29.2 k | Valuation ($) 8.8 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $2.8m (FY, 2024) | Revenue (est.) N/A | Revenue (est.) $10.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) ¥496.8b (FY, 2025) |
Net income | Net income $9.2m (FY, 2024) | Net income ($33.6m) (FY, 2025) | Net income ($153.9m) (FY, 2025) | Net income ($39.7m) (FY, 2022) | Net income ¥67b (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 88m | Total funding raised $ 491k | Total funding raised $ 101.8m | Total funding raised $ 105m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Moleculin Biotech
HQ
Houston, US
Employees
17↓ 6% decrease
Moleculin Biotech is a pharmaceutical company focused on the development of anti-cancer drug candidates.
View companyGlycoMimetics
HQ
Rockville, US
Employees
50↑ 25% increase
GlycoMimetics is a biopharmaceutical company designing and developing small molecule therapeutics to treat various cancers.
View companyCalithera Biosciences
HQ
South San Francisco, US
Employees
79↑ 8% increase
Calithera Biosciences is a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
View companyKyowa Kirin
HQ
Tokyo, JP
Employees
5,669
Kyowa Kirin (formerly Kyowa Hakko Kirin) is a pharmaceutical company focused on the areas of oncology, nephrology, immunology, and the central nervous system.
View company